Data Science in the News

From intern to mentor, Nisha Mulakken builds a career in bioinformatics

The COVID-19 pandemic has sparked a wave of new research and development at the Lab, and Nisha Mulakken is very busy. The biostatistician has enhanced the Lawrence Livermore Microbial Detection Array (LLMDA) system with detection capability for all variants of SARS-CoV-2. The technology detects a broad range of organisms—viruses, bacteria, archaea, protozoa, and fungi—and has demonstrated...

Advancing healthcare with data science (VIDEO)

This video provides an overview of projects in which data scientists work with domain scientists to address major challenges in healthcare. To help fight the COVID-19 pandemic, researchers are developing computer models to search for potential antibody and antiviral drug treatments, sharing a data portal with scientists and the general public, and analyzing drug compounds via a novel text...

COVID-19 research goes public through new portal

A new online data portal is making available to the public a wealth of data LLNL scientists have gathered from their ongoing COVID-19 molecular design projects, particularly the computer-based “virtual” screening of small molecules and designed antibodies for interactions with the SARS-CoV-2 virus for drug design purposes. The portal houses a wealth of data LLNL scientists have gathered from...

New ML platform generates novel COVID-19 antibody sequences for experimental testing

LLNL researchers have identified an initial set of therapeutic antibody sequences, designed in a few weeks using machine learning and supercomputing, aimed at binding and neutralizing SARS-CoV-2, the virus that causes COVID-19. The research team is performing experimental testing on the chosen antibody designs. Read more at LLNL News.

Upgrades for LLNL supercomputer from AMD, Penguin Computing aid COVID-19 research

Under a new agreement, AMD will supply upgraded graphics accelerators for LLNL’s Corona supercomputing cluster, expected to nearly double the system’s peak compute power. The system will be used by scientists through the public/private COVID-19 HPC Consortium, and by LLNL researchers, who are working on discovering potential antibodies and anti-viral compounds for SARS-CoV-2, the virus that...

LLNL creates web resources to aid in fight against COVID-19

LLNL is fully committed to helping protect the U.S. from COVID-19 and to speed the recovery of those affected. As a world-class research institute, we have considerable infrastructure, unique research capabilities and a dedicated team of scientists and engineers supporting the fight against the COVID-19 pandemic. Our current COVID-19 research and response activities are focused on four broad...

New partnership to unleash U.S. supercomputing resources in the fight against COVID-19

The White House announced the launch of the COVID-19 High Performance Computing Consortium to provide COVID-19 researchers worldwide with access to the world’s most powerful high performance computing resources that can significantly advance the pace of scientific discovery in the fight to stop the virus. Read more at LLNL News.

Lab antibody, anti-viral research aids COVID-19 response

LLNL scientists are contributing to the global fight against COVID-19 by combining artificial intelligence/machine learning, bioinformatics and supercomputing to help discover candidates for new antibodies and pharmaceutical drugs to combat the disease. Armed with the virus’ predicted 3D structure and a few antibodies known to bind and neutralize SARS, an LLNL team led by Daniel Faissol and...

Lab leads effort to model proteins tied to cancer

Computational scientists, biophysicists and statisticians from LLNL and Los Alamos National Laboratory(LANL) are leading a massive multi-institutional collaboration that has developed a machine learning-based simulation for next-generation supercomputers capable of modeling protein interactions and mutations that play a role in many forms of cancer. Read more at LLNL News.

Successful simulation and visualization coupling proves the power of Sierra

As the first National Nuclear Security Administration (NNSA) production supercomputer backed by GPU- (graphics processing unit) accelerated architecture, Sierra’s acquisition required a fundamental shift in how scientists at Lawrence Livermore National Laboratory (LLNL) program their codes to take advantage of the GPUs. The majority of Sierra’s computational power—95 percent of its 125...

NFL comes to Lab to hear latest on TBI research

Officials from the National Football League visited LLNL to hear how the Department of Energy’s national laboratories are using high-performance computing and artificial intelligence to advance scientific understanding of traumatic brain injury (TBI). Read more at LLNL News.

Multi-institutional meeting centers on making the 'impossible' possible in cancer research

Computer scientists, biomedical engineers, cancer biologists and bioinformaticians from eight Department of Energy national laboratories, health-related government agencies and universities converged at LLNL March 6-7 to discuss ongoing efforts to advance cancer research through computation, identify existing challenges and brainstorm future multidisciplinary projects. Read more at LLNL News...